Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Death-associated protein-like 1 (DAPL1) is a protein primarily involved in the regulation of epithelial cell homeostasis, differentiation, and apoptosis. It is highly expressed in tissues such as the retina/RPE, testis, and other epithelial linings. DAPL1 functions as a negative regulator of cell proliferation, and loss of DAPL1 leads to abnormal epithelial growth and disrupted tissue organization, as seen in knockout mouse models. In the testes, DAPL1 regulates steroidogenic pathways by influencing the expression of enzymes and factors controlling testosterone synthesis. Genomic variants in the DAPL1 locus are associated with increased susceptibility to age-related macular degeneration, especially in females. At present, DAPL1 is emerging as a disease-associated gene and a potential biomarker but is not yet a direct therapeutic target for drugs[1][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Death-associated protein-like 1 (DAPL1).